Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
1(33%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
1
33%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution1 total trials
N/ANon-phased studies
1(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

3

all time

Status Distribution
Active(1)
Completed(1)
Other(1)

Detailed Status

Recruiting1
unknown1
Completed1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
1
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A1 (100.0%)

Trials by Status

recruiting133%
unknown133%
completed133%

Recent Activity

1 active trials
Showing 3 of 3
recruiting

FebriDx® Pediatric Validation Study

NCT07211997
completed

FebriDx DISRUPT Acute Respiratory Infection Trial in Acute Respiratory Infection: An Evaluation of FebriDx® POC Test

NCT02018198
unknownnot_applicable

Point of Care Testing Using FebriDx in Primary Care: a Mixed Methods Feasibility Study

NCT05534555

Clinical Trials (3)

Showing 3 of 3 trials
NCT07211997

FebriDx® Pediatric Validation Study

Recruiting
NCT02018198

FebriDx DISRUPT Acute Respiratory Infection Trial in Acute Respiratory Infection: An Evaluation of FebriDx® POC Test

Completed
NCT05534555Not Applicable

Point of Care Testing Using FebriDx in Primary Care: a Mixed Methods Feasibility Study

Unknown

All 3 trials loaded

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
3